The aim of our study was to compare the presence of hyperandrogenic symptoms, testosterone and SHBG levels between women with and without PCOS above 45 years of age, and to study the impact of hyperandrogenism on the overall health-related quality of life in women with normoandrogenic and hyperandrogenic POCS phenotypes. This evidence concerns the gene SHBG and hyperandrogenism.